All-In-One Screener Ben Graham Lost Formula Canadian Faster Growers CEO Buys CEO Buys after Price Drop > 20% Dividend Aristocrats 2022 Dividend Growth Portfolio Dividend Income Portfolio Fast Growers Good Companies Hedge Fund Guru Top 10 Aggregated High Quality High Quality Low Capex w ROE ROC min High Quality & Low Capex High Yield Insider Buys Historical High Dividend Yields International Gurus' Top Holdings James Montier Short Screen Margin Decliners Mega Caps Peter Lynch & Warren Buffett Peter Lynch Growth w Lower Valuation Peter Lynch S&L Traded Below Book PFCF Screener Piotroski Score Screener Predictable Growth Companies Profitable predictable margin expanders Stocks Sold w less Cash The Stalwarts
Stock Ideas All-In-One Screener S&P 500 Map S&P 500 Bubble S&P 500 Aggregate Buffett-Munger Screener Industry Overview Undervalued Predictable Benjamin Graham Net-Net 52-week/3Y/5Y Lows 52-week/3Y/5Y Highs Magic Formula(Greenblatt) Dividend Stocks Peter Lynch Screen S&P500 Grid Predictable Companies Spin Off List Historical Low P/B List Historical Low P/S List High Short Interest Upcoming Special Dividends Delisted Stocks
Performances Overview Most Broadly Held Portfolio Most Weighted Portfolio Buffett-Munger Top 25 GF Score <= 100 Top 25 Top 25 Undervalued Predictable Top 25 52-week Low Predictable Top 25 Historical Low P/S
Latest Guru Picks Real Time Picks Guru Portfolio Top 10 Holdings View Guru Bargains Hot Picks Aggregated Portfolio Consensus Picks ETFS Score Board Sector Picks International Picks Industry Trends Geographic Trend Options European Shorting
Complete Guru List Warren Buffett Bill Gates Mohnish Pabrai Carl Icahn George Soros David Tepper Seth Klarman Bill Ackman Joel Greenblatt Charlie Munger Michael Price Julian Robertson Chuck Akre David Einhorn Tom Gayner
Economic Data Industry Overview U.S. Treasury Yield Curve Buffett Indicator Global Market Valuations Shiller P/E Shiller P/E by Sectors GF Value for SP500 Index Buffett Assets Allocation
The Dow Jones Industrial Average (DJIA) SP 500 Index Nasdaq Composite Index Gross Domestic Product (GDP) Shiller PE Ratio of Wilshire 5000 over GNP Civilian Unemployment Rate Russell 2000 Small Cap Price Index CBOE Volatility Index (VIX) Total Nonfarm Payrolls: All Employees More...
RYDEX SERIES FUNDS's Biotechnology Fund (RYOIX) has disclosed 54 total holdings in their latest N-PORT filing with the SEC for the portfolio date of 2022-06-30. The current portfolio value is calculated to be $137.00 Mil, only including common equities, preferred equities, ETFs, options and warrants for equities. The turnover rate is 6%.
Biotechnology Fund (RYOIX)'s Total Assets is $137.62 Mil , Total Liabilities is $218,040.00 , Net Assets is $137.40 Mil.
In Biotechnology Fund (RYOIX)'s current portfolio as of 2022-06-30, the top 5 holdings are , , , and , not including call and put options. Biotechnology Fund (RYOIX) did not buy any new stocks in the current portfolio.
Please visit the "Current Portfolio" tab to see the mutual fund's current and past N-PORT holdings for Biotechnology Fund (RYOIX), as well as holding map, valuations for each stock, which positions are undervalued, have low PE Ratios, are considered high quality and recently traded at 52-week lows, etc.
Please visit the "Stock Picks" tab to see the mutual fund's latest trades and stock picks for Biotechnology Fund (RYOIX), which include data from form N-PORT.
Please visit the "Summary" page to see the top 10 holdings, recent stock picks, performance, sector / industry breakdown details, as well as past holding history summary for Biotechnology Fund.
Biotechnology Fund Investing Philosophy
Performance of Biotechnology Fund Investor Class
GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.
© 2004-2022 GuruFocus.com, LLC. All Rights Reserved.